
DRUGS MADE IN AMERICA ACQ-RT
DMIIR · NASDAQ
更新于 2026-10-14 08:52:42
- 今日最高
- $0.09
- 今日最低
- $0.05
K线图趋势,实际资料以交易页为准
关键数据
- 昨日开盘价
- $0.05
- 昨日收盘价
- $0.07
- 成交量
- 16.42万
- 市值
- $6.49亿
- 本益比(P/E)
- 49.85X
- 每股收益(EPS)
- $0.80
昨日价格区间
52周价格区间
公司概况
- 板块
- --
- 行业
- N/A
- 子行业
- --
- 总部
- 420 LEXINGTON AVENUE, NEW YORK, NY, UNITED STATES, 10170
- 国家
- US
- 上市日期
- 2025-09-25
- 财年截止
- --
- 流通股数
- 6370万
- CIK
- --
- 官方网址
- --
Drugs Made In America Acquisition II Corp. Right (DMIIR) is a special purpose acquisition company (SPAC) strategically focused on merging with innovative pharmaceutical firms dedicated to bolstering domestic drug manufacturing capabilities. Led by an experienced management team, DMIIR is positioned to address the growing demand for affordable and accessible medications within the U.S. healthcare landscape. The company seeks to execute targeted acquisitions that not only enhance shareholder value but also contribute to the strengthening of the essential healthcare infrastructure in America, ultimately fostering a more resilient and self-sufficient pharmaceutical ecosystem.
财务指标
--
常见问题
风险提示
股价可能大幅波动,短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考,不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。